Pfizer Migraine Nasal Spray Receives FDA Approval

Pfizer Migraine Nasal Spray Receives FDA Approval

Mar 14, 2023 | News

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute treatment of migraine with or without aura in adults. In...